BALKWILL F, Berlato C, Khan MN, Schioppa T, Thompson R, Maniati E, Montfort A, Jangani M et al.(2017). A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. Journal of Clinical Investigation
Kulbe H, Iorio F, Chakravarty P, Milagre CS, Moore R, Thompson RG, Everitt G, Canosa M et al.(2016). Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells. Oncotarget vol. 7, (13) 15648-15661.
Berlato C, Chan KYV, Price AM, Canosa M, Scibetta AG, Hurst HC(2011). Alternative TFAP2A isoforms have distinct activities in breast cancer. Breast Cancer Research vol. 13, (2)
Scibetta AG, Wong PP, Chan KYV, Canosa M, Hurst HC(2010). Dual association by TFAP2A during activation of the p21cip/CDKN1A promoter. Cell Cycle vol. 9, (22) 4525-4532.
Williams CMJ, Scibetta AG, Friedrich JK, Canosa M, Berlato C, Moss CH, Hurst HC(2009). AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO J vol. 28, (22) 3591-3601.
Williams CMJ, Scibetta AG, Friedrich JK, Canosa M, Berlato C, Moss CH, Hurst HC(2009). AP-2γ promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO Journal vol. 28, (22) 3591-3601.